The world’s leading Rapamycin researcher, Dr. Mikhail Blagosklonny, has a long background in cancer research and one important discovery he made around 2000 was that Rapamycin slowed down senescent cancer cells in different ways. After that step-by-step, his interest in the longevity field increased and he developed the very interesting hyperfunction theory of aging.
He has made a huge contribution in moving the Rapamycin longevity field forward and his research papers have impacted many people. For example, the Rapamycin physician Alan Green who – thanks to these papers – took the decision in 2017 to start prescribing Rapamycin off label. Today, Alan Green has the biggest clinical experience in the area with more than 1,200 patients. A lot of other physicians have after that also taken these steps and one of those, for example, is physician Peter Attia.
Interview Table of Contents:
- 02:32 Current situation and mission
- 04:07 Why did Rapamycin not prevent his cancer?
- 06:33 He develops a new type of cancer treatment
- 08:32 Hyperfunction theory of age-related diseases
- 10:38 mTOR drives age-related diseases
- 13:00 Hyperfunction theory and the car analogy
- 17:20 Difference between new and old version of hyperfunction theory
- 19:58 Prediction based on hyperfunction theory
- 21:38 Rapamycin seems to work at any age
- 23:55 Rapamycin will not make you immortal
- 26:21 Rapamycin delays lung cancer in mice
- 27:44 Hyperfunction theory and hormesis
- 29:13 Rapamycin combination with fasting or calorie restriction
- 30:33 Rapamycin combination with Acarbose or low carb diet
- 31:40 Rapamycin combination with exercise
- 33:04 Exercise and longevity effect
- 36:10 mTOR sweet spot
- 38:44 Why do centenarians live a long life?
- 40:36 Theory of accumulation of molecular damage
- 44:04 Hyperfunction theory was initially rejected
- 47:47 Rapamycin research that is missing
- 51:44 Rapamycin and bacterial infection
- 53:30 Rapamycin side effect on longevity dose regime
- 55:50 Rapamycin and pseudo-diabetes
- 58:51 Rapamycin combination of Acarbose or low carb diet
- 1:00:09 Rapamycin and increase in lipids
- 1:02:19 mTOR, mTORC1 and mTORC2
- 1:05:22 Mikhail’s self-experimentation with Rapamycin
- 1:10:41 Rapamycin and traditional medical care
- 1:11:13 Rapamycin and unacceptable side effects
- 1:14:26 Rapamycin and combinations to avoid
- 1:16:55 Rapamycin and high protein intake
- 1:18:08 Best time to start taking Rapamycin
- 1:21:00 Does Rapamycin prevent cancer or not?
- 1:23:52 Autophagy is a double-edged sword
- 1:26:51 Important insight from his cancer
- 1:28:38 Rapamycin rebound effect
- 1:30:24 Difference between theory and practice
- 1:32:45 Mikhail’s cancer and cancer treatment
- 1:37:36 Rapamycin and danger
Dr. Blagosklonny’s Links:
- Research publications – https://pubmed.ncbi.nlm.nih.gov/?term…
- X/Twitter – https://twitter.com/Blagosklonny
- Website – https://www.mikhailblagosklonny.com
Rapamycin resources:
- Rapamycin.news – https://www.rapamycin.news
- Rapamycin Facebook group – https://www.facebook.com/groups/rapam…
- Rapamycin Reddit group – https://www.reddit.com/r/Rapamycin/
Disclaimer from host Krister Kauppi:
The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.